Fred Alger Management, LLC Allogene Therapeutics, Inc. Transaction History

Fred Alger Management, LLC

  • $19.8 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 13, 2020
SELL
$32.38 - $44.96 $420,940 - $584,480
-13,000 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$18.39 - $54.04 $239,070 - $702,520
13,000 New
13,000 $557,000
Q2 2019

Aug 14, 2019
SELL
$25.56 - $31.09 $127,800 - $155,450
-5,000 Closed
0 $0
Q1 2019

May 14, 2019
BUY
$24.82 - $32.54 $124,100 - $162,700
5,000 New
5,000 $145,000

Others Institutions Holding ALLO

# of Institutions
163
Shares Held
134M
Call Options Held
59.4K
Put Options Held
113K
View Full List

About Allogene Therapeutics, Inc.

ALLO Quotes by TradingView
  • Ticker ALLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 143,807,008
  • Market Cap $262M
  • Description
  • Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...
More about ALLO
Track This Portfolio

Track Fred Alger Management, LLC Portfolio

Follow Fred Alger Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fred Alger Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email